Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Pneumonia%2C+Bacterial%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22
/vufind/Search/Results?lookfor=%22Pneumonia%2C+Bacterial%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22
Search /vufind/Search2/Results?lookfor=%22Pneumonia%2C+Bacterial%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22
PubPharm (29)
1
Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia : A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of CAL02 Administered Intravenously in Addition to Standard of Care in Subjects With Severe Community-Acquired Bacterial Pneumonia (SCABP)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Pneumonia Direct Pilot : Pneumonia Direct Pilot
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia : A Randomized, Placebo-controlled, Double-blind, Multi-center, Phase III Trial to Assess the Efficacy and Safety of Trimodulin (BT588) in Adult Hospitalized Subjects With CAP Including COVID-19 Pneumonia.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia : A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of CAL02 Administered Intravenously in Addition to Standard of Care in Subjects With Severe Community-Acquired Bacterial Pneumonia (SCABP)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101 : A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101, an Anti-DNABII Monoclonal Antibody, in Healthy Subjects (Part 1) and Hospitalized Subjects With Suspected or Confirmed Community-Acquired Bacterial Pneumonia of Moderate Severity (Part 2)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia : A Phase 3b Randomized, Double-Blind, Multi-Center Study to Compare the Safety and Efficacy of Omadacycline IV/PO to Moxifloxacin IV/PO for Treating Adult Subjects With Community-Acquired Bacterial Pneumonia (CABP)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients : Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants : An Open-label Study With a Nonrandomized Single-dose Phase in Subjects With Suspected or Confirmed Aerobic Gram-negative Bacterial Infections Followed by a Randomized, Multiple-dose, Active-controlled Phase in Subjects With Suspected or Confirmed Complicated Urinary Tract Infection (cUTI), Hospital-acquired Bacterial Pneumonia (HABP) or Ventilator-associated Bacterial Pneumonia (VABP) to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Subjects 3 Months to < 18 Years of Age
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101 : A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101, an Anti-DNABII Monoclonal Antibody, in Healthy Subjects (Part 1) and Hospitalized Subjects With Suspected or Confirmed Community-Acquired Bacterial Pneumonia of Moderate Severity (Part 2)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Fosfomycin i.v. for Treatment of Severely Infected Patients : An International, Multicentre, Non-comparative, Non-interventional, Prospective Clinical Registry to Evaluate the Clinical Outcome and Safety of the Treatment of Severely Infected Patients With Fosfomycin i.v.
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Recruiting
Medienart
29
Aufsätze
29
E-Artikel
29
E-Ressourcen
Zeitschriftentitel
23
ClinicalTrials.gov
6
WHO International Clinical Trials Registry Plat...
Thema
29
610
Recruitment Status: Recruiting
23
Pneumonia, Bacterial
23
Study Type: Interventional
20
Pneumonia
6
Study Type: Observational
4
Phase: Phase 3
4
Pneumonia, Viral
4
Urinary Tract Infections
3
Communicable Diseases
3
Infections
3
Phase: Phase 2
2
Bacterial Infections
2
Cystic Fibrosis
2
Fibrosis
2
Intraabdominal Infections
2
Medical Condition: Bacterial pneumonia. Bacteri...
2
Medical Condition: Condition 1: community acqui...
2
Medical Condition: Pneumonia, Bacterial.;C01.25...
2
Phase: Phase 1
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
24
2020-
5
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
29
Englisch
Haven't found what you're looking for?
Wird geladen...